Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including BQ and XBB lineages https://www.biorxiv.org/content/10.1101/2023.07.18.549524v1?med=mas
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including BQ and XBB lineages https://www.biorxiv.org/content/10.1101/2023.07.18.549524v1?med=mas